tradingkey.logo

BioLife Solutions Inc

BLFS
View Detailed Chart
24.900USD
-0.510-2.01%
Close 12/26, 16:00ETQuotes delayed by 15 min
1.19BMarket Cap
LossP/E TTM

BioLife Solutions Inc

24.900
-0.510-2.01%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.01%

5 Days

-0.68%

1 Month

-6.67%

6 Months

+15.92%

Year to Date

-4.08%

1 Year

-7.88%

View Detailed Chart

Key Insights

BioLife Solutions Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 32.10.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

BioLife Solutions Inc's Score

Industry at a Glance

Industry Ranking
17 / 207
Overall Ranking
89 / 4563
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 10 analysts
Buy
Current Rating
32.100
Target Price
+28.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

BioLife Solutions Inc Highlights

StrengthsRisks
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Growing
The company is in a growing phase, with the latest annual income totaling USD 82.25M.
Undervalued
The company’s latest PE is -448.89, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.86M shares, decreasing 1.47% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 80.95K shares of this stock.

BioLife Solutions Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

BioLife Solutions Inc Info

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Ticker SymbolBLFS
CompanyBioLife Solutions Inc
CEODe Greef (Roderick)
Websitehttps://www.biolifesolutions.com/

FAQs

What is the current price of BioLife Solutions Inc (BLFS)?

The current price of BioLife Solutions Inc (BLFS) is 24.900.

What is the symbol of BioLife Solutions Inc?

The ticker symbol of BioLife Solutions Inc is BLFS.

What is the 52-week high of BioLife Solutions Inc?

The 52-week high of BioLife Solutions Inc is 29.620.

What is the 52-week low of BioLife Solutions Inc?

The 52-week low of BioLife Solutions Inc is 19.100.

What is the market capitalization of BioLife Solutions Inc?

The market capitalization of BioLife Solutions Inc is 1.19B.

What is the net income of BioLife Solutions Inc?

The net income of BioLife Solutions Inc is -20.18M.

Is BioLife Solutions Inc (BLFS) currently rated as Buy, Hold, or Sell?

According to analysts, BioLife Solutions Inc (BLFS) has an overall rating of Buy, with a price target of 32.100.

What is the Earnings Per Share (EPS TTM) of BioLife Solutions Inc (BLFS)?

The Earnings Per Share (EPS TTM) of BioLife Solutions Inc (BLFS) is -0.055.
KeyAI